Table 1.

Patient characteristics

CharacteristicValue
Total no.52
Median age (y)54 (range, 37-68)
Gender
    Female26 (50%)
    Male26 (50%)
Ethnicity
    African-American22 (42%)
    Caucasian49 (56%)
    Asian1 (2%)
Prior therapy
    Median no.1 (range, 1-3)
    % Bortezomib treated28%
    % Thalidomide/lenalidomide treated74%
    % Received radiotherapy14%
Cytogenetics
    Abnormal41%
    Normal59%
Myeloma subtypes
    IgA27%
    IgG68%
    Light chain5%